New research propose that Delta-Sleep-Inducing Peptide Compound represents the promising clinical candidate. Initial results have the role in regulating circadian rhythms and potentially treating several sleep-related conditions . Further study are essential to completely understand a process of impact and substantiate a therapeutic application in